K V Pharmaceutical Company (KV-A)
Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.
Recs
Should be a slam-dunk outperformer with a solid product line and clear of FDA issues.
Recs
Infrastructure problem will be fixed
Recs
This company has been around for a while, and survived some challenging markets. The issues with the FDA will turn out to be a cloud with a silver lining. Any corporation or organisation that survives the rigours of an FDA intervention, is a stable and attractive stock pick. KV.A is already showing signs of revitalisation.
Recs
I don't think that this stock may have a little run based on artificial media hype, but don't believe the company has really that much to offer to create solid stock gains. So they are developing products to save money in manufacturing supplements and drugs and are also marketing generics. Big deal. There's safer and better places to put my money.
Recs
In reading the SEC filings and the FDA citations, this company on a wholesale basis at almost every site they manage has undermaintained equipment, responded inappropriately or not at all to quality concerns, and run their machinery at rates that were higher than equipment capacity. IMHO this can only mean one thing: lack of attention to quality, excellence and ethics at the highest levels. Read the filings and statements. Each filing for why financial statements are not produced have the statement saying the company has doubts whther or not it will continue to be a "going concern:. This statement is one they legaly must make if they are not sure they will be able to keep the company solvent. Not sure how they will with no production to speak of for most of 2009, recalls, and no current for sale production. This is a long shot people...wait to see how the trials go and whether their board of directors changes. BTW, a good way to post industry leading profits for the short term is to do the things the FDA cited them for...
Recs
Taking a flier on these guys. Don't have much history on them, but fundamentals appear solid for the time being. Good buy under $5 in my opinion.
Recs
This should yield some good profits.. They still have some road bumps ahead with the FDA action but, generics are the future.
Recs
All Star Portfolio
Recs
Betting for a turn around.
Recs
Shooting dead fish in a barrel could not be easier than making money on this stock!!
Recs
I agree with some fantastic earlier pitches. The company should be in recovery mode and should rise handsomely.
Recs
2.17 PE, it has to be either undervalued or the Fool's system is out of wack...........
Go for it Fools.............
Recs
Recommendation of cap member and/or remembers to at least double with in six months or less
Recs
I believe it will be a good solid pharmaceutical stock, over the long term
Recs
This stock is VERY cheap. Is it cheap enough? Probably. Read this Fool review: http://www.fool.com/investing/value/2009/09/30/this-is-the-markets-cheapest-stock.aspx.
I won't buy any. It's still not a great stock. It's just cheap enough to make it worth putting a thumbs up on
Recs
This is a fantastic stock! can't go wrong with this pick! Show me the Money like Jerry MaGuire!
Recs
Just watching. Drug company.
Recs
Betting on Caps that they get their approvals and start rolling again. Not putting real money on it.
Recs
I recently purchased this stock in the $3 range. When you subtract out the companies somewhat recent negatives i.e. law violations etc.. the companies long term fundamentals & profitability appear to be intact. I like the upside, it certainly has been beat down.... with the potential to rise again.
Recs
It looks really good long term, I see it going right back to it's mean or higher in next couple of years.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 51 1 2 3 Next »